![Markus Loeffler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Markus Loeffler
Director Técnico/Científico/I+D en NH THERAGUIX SAS .
Perfil
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Cargos activos de Markus Loeffler
Empresas | Cargo | Inicio |
---|---|---|
NH THERAGUIX SAS | Director Técnico/Científico/I+D | 01/01/2020 |
Formación de Markus Loeffler.
INSEAD | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
NH TherAguix SAS
![]() NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
- Bolsa de valores
- Insiders
- Markus Loeffler